The GDC, established in LTTS’ Mobility segment, will strengthen PALFINGER’s localization roadmap and next-gen digital ...

Pharmaceutical Technology Co., Ltd. (“Biocytogen,” SSE: 688796; HKEX: 02315), a global biotechnology company advancing ...

Expansion in Asia-Pacific with second subsidiary, following Australia, pivotal to enrolling patients in phase II trial targeting ALS, a motor neuron disease with no cure ALS patient incidence rate in ...

Igyxos Biotherapeutics, a biotechnology company dedicated to developing innovative monoclonal antibodies for infertility treatment, today announced the successful completion of its Phase 1 clinical ...

Collaboration leverages OBT's proprietary OGAP®-Verify platform and GSK's drug development expertise to advance multiple selected novel oncology targets▪         The agreement - OBT's second ...

OverviewThe global patient handling equipment market is anticipated to grow at a steady CAGR of around 6% over the forecast period, supported by strong demographic trends, growing safety regulations, ...

Global Ophthalmology Drugs Market OutlookThe global ophthalmology drugs market is forecasted to expand at a CAGR of nearly 8% over the next several years, driven by the rising burden of vision ...

Poised for Rapid GrowthThe Global Augmented Reality (AR) and Virtual Reality (VR) in Healthcare Market is projected to grow at a remarkable CAGR of 30–35% over the next five years. This surge is ...

Unique ContentThe global medical connectors market is anticipated to grow steadily at a CAGR of approximately 7% during the forecast period, supported by the rising adoption of minimally invasive ...

Global Anatomic Pathology Market OverviewThe global anatomic pathology market is poised for a strong growth trajectory, expected to expand at a CAGR of nearly 8% during the forecast period. This ...

Polpharma Biologics, a leading biopharmaceutical company specializing in the development and manufacturing of biosimilars, is thrilled to announce the signing of a landmark licensing agreement with ...

MRD-negative response rate in four patients; all remain in response through the longest follow up of 5 monthsFavorable ...